Skip to main content
Erschienen in:

11.09.2023 | Magnetic Resonance

Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study

verfasst von: Feier Ding, Min Huang, Ping Ren, Junlei Zhang, Zhengyu Lin, Yan Sun, Changhu Liang, Xinya Zhao

Erschienen in: European Radiology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the value of quantitative parameters derived from gadobenate dimeglumine–enhanced magnetic resonance imaging (MRI) for predicting molecular subtype of hepatocellular carcinoma (HCC) and overall survival.

Methods

This multicenter retrospective study included 218 solitary HCC patients who underwent gadobenate dimeglumine–enhanced MRI. All HCC lesions were resected and pathologically confirmed. The lesion-to-liver contrast enhancement ratio (LLCER) and lesion-to-liver contrast (LLC) were measured in the hepatobiliary phase. Potential risk factors for proliferative HCC were assessed by logistic regression. The ability of LLCER and LLC to predict proliferative HCC was assessed by the receiver operating characteristic (ROC) curve. Prognostic factors were evaluated using the Cox proportional hazards regression model for survival outcomes.

Results

LLCER was an independent predictor of proliferative HCC (odds ratio, 0.015; 95% confidence interval [CI], 0.008–0.022; p < 0.001). The area under the ROC curve was 0.812 (95% CI, 0.748–0.877), higher than that of LLC, alpha-fetoprotein > 100 ng/ml, satellite nodules, and rim arterial phase hyperenhancement (all p ≤ 0.001). HCC patients with LLCER < −4.59% had a significantly higher incidence of proliferative HCC than those with the LLCER ≥ −4.59%. During the follow-up period, LLCER was an independent predictor of overall survival (hazard ratio, 0.070; 95% CI, 0.015–0.324; p = 0.001) in HCC patients.

Conclusions

Gadobenate dimeglumine–enhanced quantitative parameter in the hepatobiliary phase can predict the proliferative subtype of solitary HCC with a moderately high accuracy.

Clinical relevance statement

Quantitative information from gadobenate dimeglumine–enhanced MRI can provide crucial information on hepatocellular carcinoma subtypes. It might be valuable to design novel therapeutic strategies, such as targeted therapies or immunotherapy.

Key Points

The lesion-to-liver contrast enhancement ratio (LLCER) is an independent predictor of proliferative hepatocellular carcinoma (HCC).
The ability of LLCER to predict proliferative HCC outperformed lesion-to-liver contrast, alpha-fetoprotein > 100 ng/ml, satellite nodules, and rim arterial phase hyperenhancement.
HCC patients with LLCER < −4.59% had a significantly higher incidence of proliferative HCC than those with the LLCER ≥ −4.59%.
Literatur
2.
Zurück zum Zitat Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A (2020) Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:139–152CrossRefPubMed Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A (2020) Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:139–152CrossRefPubMed
3.
Zurück zum Zitat Calderaro J, Ziol M, Paradis V, Zucman-Rossi J (2019) Molecular and histological correlations in liver cancer. J Hepatol 71:616–630CrossRefPubMed Calderaro J, Ziol M, Paradis V, Zucman-Rossi J (2019) Molecular and histological correlations in liver cancer. J Hepatol 71:616–630CrossRefPubMed
5.
Zurück zum Zitat Torbenson MS (2021) Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes. Hum Pathol 112:86–101CrossRefPubMed Torbenson MS (2021) Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes. Hum Pathol 112:86–101CrossRefPubMed
6.
Zurück zum Zitat Calderaro J, Couchy G, Imbeaud S et al (2017) Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol 67:727–738CrossRefPubMed Calderaro J, Couchy G, Imbeaud S et al (2017) Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol 67:727–738CrossRefPubMed
7.
Zurück zum Zitat Ziol M, Pote N, Amaddeo G et al (2018) Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology 68:103–112CrossRefPubMed Ziol M, Pote N, Amaddeo G et al (2018) Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology 68:103–112CrossRefPubMed
8.
Zurück zum Zitat Seok JY, Na DC, Woo HG et al (2012) A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 55:1776–1786CrossRefPubMed Seok JY, Na DC, Woo HG et al (2012) A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 55:1776–1786CrossRefPubMed
9.
10.
Zurück zum Zitat Vernuccio F, Rosenberg MD, Meyer M, Choudhury KR, Nelson RC, Marin D (2019) Negative biopsy of focal hepatic lesions: decision tree model for patient management. AJR Am J Roentgenol 212:677–685CrossRefPubMed Vernuccio F, Rosenberg MD, Meyer M, Choudhury KR, Nelson RC, Marin D (2019) Negative biopsy of focal hepatic lesions: decision tree model for patient management. AJR Am J Roentgenol 212:677–685CrossRefPubMed
11.
Zurück zum Zitat Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (</= 2 cm) HCC in cirrhosis. Eur Radiol 21:1233–1242CrossRefPubMed Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (</= 2 cm) HCC in cirrhosis. Eur Radiol 21:1233–1242CrossRefPubMed
12.
Zurück zum Zitat Roberts LR, Sirlin CB, Zaiem F et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology 67:401–421CrossRefPubMed Roberts LR, Sirlin CB, Zaiem F et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology 67:401–421CrossRefPubMed
13.
Zurück zum Zitat Kang H-J, Kim H, Lee DH et al (2021) Gadoxetate-enhanced MRI features of proliferative hepatocellular carcinoma are prognostic after surgery. Radiology 300:572–582CrossRefPubMed Kang H-J, Kim H, Lee DH et al (2021) Gadoxetate-enhanced MRI features of proliferative hepatocellular carcinoma are prognostic after surgery. Radiology 300:572–582CrossRefPubMed
14.
Zurück zum Zitat Rhee H, An C, Kim HY, Yoo JE, Park YN, Kim MJ (2019) Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features. Liver Cancer 8:24–40CrossRefPubMed Rhee H, An C, Kim HY, Yoo JE, Park YN, Kim MJ (2019) Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features. Liver Cancer 8:24–40CrossRefPubMed
15.
Zurück zum Zitat Rong D, He B, Tang W et al (2022) Comparison of gadobenate-enhanced MRI and gadoxetate-enhanced MRI for hepatocellular carcinoma detection using LI-RADS version 2018: a prospective intraindividual randomized study. AJR Am J Roentgenol 218:687–698CrossRefPubMed Rong D, He B, Tang W et al (2022) Comparison of gadobenate-enhanced MRI and gadoxetate-enhanced MRI for hepatocellular carcinoma detection using LI-RADS version 2018: a prospective intraindividual randomized study. AJR Am J Roentgenol 218:687–698CrossRefPubMed
16.
Zurück zum Zitat Roux M, Pigneur F, Calderaro J et al (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenoma: role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 42:1249–1258CrossRefPubMed Roux M, Pigneur F, Calderaro J et al (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenoma: role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 42:1249–1258CrossRefPubMed
17.
Zurück zum Zitat Reizine E, Amaddeo G, Pigneur F et al (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 28:4243–4253CrossRefPubMed Reizine E, Amaddeo G, Pigneur F et al (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 28:4243–4253CrossRefPubMed
18.
Zurück zum Zitat Mule S, Chalaye J, Legou F et al (2020) Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. Eur Radiol 30:5348–5357CrossRefPubMed Mule S, Chalaye J, Legou F et al (2020) Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. Eur Radiol 30:5348–5357CrossRefPubMed
20.
Zurück zum Zitat Cerny M, Chernyak V, Olivie D et al (2018) LI-RADS version 2018 ancillary features at MRI. Radiographics 38:1973–2001CrossRefPubMed Cerny M, Chernyak V, Olivie D et al (2018) LI-RADS version 2018 ancillary features at MRI. Radiographics 38:1973–2001CrossRefPubMed
21.
Zurück zum Zitat Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336–343CrossRefPubMed Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336–343CrossRefPubMed
22.
Zurück zum Zitat Wiesner R, Edwards E, Freeman R et al (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91–96CrossRefPubMed Wiesner R, Edwards E, Freeman R et al (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91–96CrossRefPubMed
23.
Zurück zum Zitat Son J, Hwang SH, Park S et al (2019) Imaging features of hepatocellular carcinoma: quantitative and qualitative comparison between MRI-enhanced with Gd-EOB-DTPA and Gd-DTPA. Invest Radiol 54:494–499CrossRefPubMed Son J, Hwang SH, Park S et al (2019) Imaging features of hepatocellular carcinoma: quantitative and qualitative comparison between MRI-enhanced with Gd-EOB-DTPA and Gd-DTPA. Invest Radiol 54:494–499CrossRefPubMed
24.
Zurück zum Zitat An C, Kim MJ (2019) Imaging features related with prognosis of hepatocellular carcinoma. Abdom Radiol (NY) 44:509–516CrossRefPubMed An C, Kim MJ (2019) Imaging features related with prognosis of hepatocellular carcinoma. Abdom Radiol (NY) 44:509–516CrossRefPubMed
25.
Zurück zum Zitat Kim KA, Kim MJ, Jeon HM et al (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed Kim KA, Kim MJ, Jeon HM et al (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed
26.
Zurück zum Zitat Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver - a study of 100 cases among 48,900 necropsies. Cancer 7:462–503CrossRefPubMed Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver - a study of 100 cases among 48,900 necropsies. Cancer 7:462–503CrossRefPubMed
27.
Zurück zum Zitat Shi F, Wu M, Lian SS et al (2019) Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: long-term outcomes. Radiology 293:707–715CrossRefPubMed Shi F, Wu M, Lian SS et al (2019) Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: long-term outcomes. Radiology 293:707–715CrossRefPubMed
28.
Zurück zum Zitat Lee DH, Lee JM, Chang W et al (2018) Prognostic role of liver stiffness measurements using magnetic resonance elastography in patients with compensated chronic liver disease. Eur Radiol 28:3513–3521CrossRefPubMed Lee DH, Lee JM, Chang W et al (2018) Prognostic role of liver stiffness measurements using magnetic resonance elastography in patients with compensated chronic liver disease. Eur Radiol 28:3513–3521CrossRefPubMed
29.
Zurück zum Zitat McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276–282CrossRefPubMed McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276–282CrossRefPubMed
30.
Zurück zum Zitat Bantis LE, Nakas CT, Reiser B (2014) Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point. Biometrics 70:212–223MathSciNetCrossRefPubMed Bantis LE, Nakas CT, Reiser B (2014) Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point. Biometrics 70:212–223MathSciNetCrossRefPubMed
31.
Zurück zum Zitat Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066CrossRefPubMed Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066CrossRefPubMed
32.
Zurück zum Zitat An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276:433–443CrossRefPubMed An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276:433–443CrossRefPubMed
33.
Zurück zum Zitat Nakachi K, Tamai H, Mori Y et al (2014) Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography. Cancer Imaging 14:7CrossRefPubMedPubMedCentral Nakachi K, Tamai H, Mori Y et al (2014) Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography. Cancer Imaging 14:7CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Yoneda N, Matsui O, Kobayashi S et al (2019) Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. Jpn J Radiol 37:191–208CrossRefPubMed Yoneda N, Matsui O, Kobayashi S et al (2019) Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. Jpn J Radiol 37:191–208CrossRefPubMed
35.
Zurück zum Zitat Zhao QY, Liu SS, Fan MX (2022) Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study. J Gastrointest Oncol 13:792–801CrossRefPubMedPubMedCentral Zhao QY, Liu SS, Fan MX (2022) Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study. J Gastrointest Oncol 13:792–801CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Qin LX, Tang ZY (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 8:193–199CrossRefPubMedPubMedCentral Qin LX, Tang ZY (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 8:193–199CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Wang JP, Yao ZG, Sun YW et al (2020) Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 26:4327–4342CrossRefPubMedPubMedCentral Wang JP, Yao ZG, Sun YW et al (2020) Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 26:4327–4342CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Bae JS, Kim JH, Lee DH, Kim JH, Han JK (2021) Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE. Eur Radiol 31:3627–3637CrossRefPubMed Bae JS, Kim JH, Lee DH, Kim JH, Han JK (2021) Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE. Eur Radiol 31:3627–3637CrossRefPubMed
39.
Zurück zum Zitat Xu XF, Xing H, Han J et al (2019) Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg 154:209–217CrossRefPubMed Xu XF, Xing H, Han J et al (2019) Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg 154:209–217CrossRefPubMed
Metadaten
Titel
Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study
verfasst von
Feier Ding
Min Huang
Ping Ren
Junlei Zhang
Zhengyu Lin
Yan Sun
Changhu Liang
Xinya Zhao
Publikationsdatum
11.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 4/2024
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10227-9

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.